ReviewPathologie (Heidelberg, Germany)2026
Molecular pathology in the diagnosis of cutaneous melanoma.
Review in Pathologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Histopathological assessment of melanocytic proliferations remains the gold standard for their correct classification. The most recent 5th edition of the World Health Organization (WHO) classification of melanocytic tumours incorporates cumulative sun damage and, in particular, molecular genetic changes to achieve this task, and recognizes nine different genetic pathways leading to melanoma development. Melanoma is therefore not a single disease genetically, but rather represents nine different well-defined clinicopathological entities that differ in terms of biological behaviour and their response to various treatment modalities. In this article, genetic pathways in the development of cutaneous melanoma are reviewed, and practical recommendations for pathologists with regards to molecular testing are provided.
Indexed as
Identifiers
42696149What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.